Related Experiment Video
Updated: Jun 4, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Surface cues shape procoagulant properties of amyloidogenic microclots
Etheresia Pretorius1,2, Chantelle Venter3, Massimo Nunes4
1Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa. resiap@sun.ac.za.
Cell membranes orchestrate thrombo-inflammation through protein misfolding and phosphatidylserine (PS) exposure. New research identifies fibrinaloid microclot complexes (FMCs) as key drivers of vascular pathology in inflammatory syndromes.
Area of Science:
- Biochemistry
- Immunology
- Pathology
Background:
- Vascular homeostasis relies on membrane integrity, glycocalyx, and receptor regulation.
- Inflammation and cell death disrupt membrane asymmetry, exposing procoagulant surfaces.
- Protein misfolding and damage to glycosaminoglycans contribute to thrombo-inflammation.
Purpose of the Study:
- To review the interconnectedness of hypercoagulability, immunothrombosis, and protein misfolding.
- To introduce fibrinaloid microclot complexes (FMCs) as a novel concept in vascular pathology.
- To elucidate the role of FMCs in inflammatory and post-viral syndromes.
Main Methods:
- Review of existing literature on cell membranes, coagulation, and protein misfolding.
- Analysis of how cellular debris, microparticles, and immune complexes form FMCs.
- Characterization of FMCs, including their β-sheet-rich features and resistance to fibrinolysis.
Main Results:
- Cellular damage exposes phosphatidylserine (PS) and amyloidogenic surfaces, promoting coagulation.
- Fibrinogen interacts with various factors to form circulating fibrinaloid microclot complexes (FMCs).
- FMCs exhibit distinct properties, including resistance to fibrinolysis, implicating them in disease.
Conclusions:
- FMCs represent a convergence of membrane damage, protein misfolding, and coagulation.
- Understanding FMCs offers new insights into the pathogenesis of systemic inflammatory diseases.
- FMCs provide a framework for comprehending pathological clotting in inflammatory and post-infectious vascular syndromes.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Clot Retraction and Fibrinolysis
Alzheimer Disease ll: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins

